Sepsis studies need new direction (Q64132695)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Sepsis studies need new direction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Jonathan Cohen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Steven Opal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

503-505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of recombinant human activated protein C for severe sepsis

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970136-6

7 January 2021

Improving clinical trials in the critically ill: unique challenge--sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970136-6

7 January 2021

Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970136-6

7 January 2021

An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970136-6

7 January 2021

A genomic storm in critically injured humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970136-6

7 January 2021

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970136-6

7 January 2021

Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970136-6

7 January 2021

10.1016/S1473-3099(12)70136-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22742624%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference